2004HU318
* With regard to a medicinal use invention which requires descriptions about pharmacological effects thereof, save exceptional cases where a pharmacological mechanism showing the pharmacological effects disclosed in the specification is well-known before filing a patent application, the specification of the patent application should describe specific experimental examples regarding pharmacological data showing that a specific substance exhibits such pharmacological effects, or is described so specifically as to replace such experimental examples. Only in such a case, an invention is considered to be complete and the patent application complies with the description requirements of the specification (see Supreme Court Decision 2004HU318, January 27, 2006).
* With regard to medicinal use inventions which require descriptions about pharmacological effects thereof, the specification of the patent application should describe specific experimental examples regarding pharmacological data showing that a specific substance exhibits such pharmacological effects. Only in such a case is an invention considered to be completed and the patent application complies with the description requirements of the specification (see Supreme Court Decision 2004HU318, January 27, 2006).
* With regard to medicinal use inventions which require descriptions about pharmacological effects thereof, the specification of the patent application should describe specific experimental examples regarding pharmacological data showing that a specific substance exhibits such pharmacological effects. Only in such a case is an invention considered to be completed and the patent application complies with the description requirements of the specification (see Supreme Court Decision 2004HU318, January 27, 2006).